No audible wheezing: Nuggets and conundrums from mouse asthma models

Journal of Experimental Medicine

Volumn 201, Issue 12, 2005, Pages 1869-1873

  Boyce, Joshua A ^a   Austen, K Frank ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; EOTAXIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIX METALLOPROTEINASE; METHACHOLINE; OVALBUMIN; PROTEIN SUBUNIT; STAT6 PROTEIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

AIRWAY; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTING CELL; ASTHMA; B LYMPHOCYTE; BIOACCUMULATION; CYTOKINE PRODUCTION; EOSINOPHIL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENE CLUSTER; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; HELMINTH; HOST PARASITE INTERACTION; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; KNOCKOUT GENE; KNOCKOUT MOUSE; MAST CELL; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SENSITIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH2 CELL; TISSUE DISTRIBUTION; TRICHINELLA SPIRALIS; WHEEZING; WILD TYPE;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; EOSINOPHILS; IMMUNOGLOBULIN E; MAST CELLS; MICE; MICE, MUTANT STRAINS; PNEUMONIA; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 22344457252     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050584     Document Type: Review

References (36)

1. Robinson, D.S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
2. Carroll, N.G., S. Mutavdzic, and A.L. James. 2002. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur. Resp. J. 19:879-885.
3. Brightling, C.E., P. Bradding, F.A. Symon, S.T. Holgate, A.J. Wardlaw, and I.D. Pavord. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346:1699-1705.
4. Hopp, R.J., R.G. Townley, R.E. Biven, A.K. Bewtra, and N.M. Nair. 1990. The presence of airway reactivity before the development of asthma. Am. Rev. Respir. Dis. 141:2-8.
5. Paggiaro, P.L., F.L. Dente, M.C. Morelli, L. Bancalari, A. Di Franco, D. Giannini, B. Vagaggini, E. Bacci, L.M. Fabbri, and C. Giuntini. 1994. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am. J. Respir. Crit. Care Med. 149:1447-1451.
6. Corry, D.B., G. Grunig, H. Hadeiba, V.P. Kurup, M.L. Warnock, D. Sheppard, D.M. Rennick, and R.M. Locksley. 1998. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4:344-355.
7. Linehan, L.A., W.D. Warren, P.A. Thompson, M.J. Grusby, and M.T. Berton. 1998. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J. Immunol. 161:302-310.
8. Corry, D.B., H.G. Folkesson, M.L. Warnock, D.J. Erle, M.A. Matthay, J.P. Wiener-Kronish, and R.M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
9. 4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med.178:2213-2218.
10. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, C.L. Karp, and D.D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science. 282:2258-2261.
11. Mould, A.W., A.J. Ramsay, K.I. Matthaei, I.G. Young, M.E. Rothenberg, and P.S. Foster. 2000. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. J. Immunol. 164:2142-2150.
12. Lee, C.G., R.J. Homer, Z. Zhu Z, S. Lanone, X. Wang, V. Koteliansky, J.M. Shipley, P. Gotwals, P. Noble, Q. Chen, R.M. Senior, and J.A. Elias. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta 1. J. Exp. Med. 194:809-821.
13. Bix, M., Z.E. Wang, B. Thiel, N.J. Schork, and R.M. Locksley. 1998. Genetic regulation of commitment to interleukin 4 production by a CD4+ T cell-intrinsic mechanism. J. Exp. Med. 188:2289-2299.
14. McIntire, J.J., S.E. Umetsu, O. Akbari, M. Potter, V.K. Kuchroo, G.S. Barsh, G.J. Freeman, D.T. Umetsu, and R.H. DeKruyff. 2001. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2:1109-1116.
15. Martin, T.R., N.P. Gerard, S.J. Galli, and J.M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:2318-2323.
16. De Sanctis, G.T., M. Merchant, D.R. Beier, R.D. Dredge, J.K. Grobholz, T.R. Martin, E.S. Lander, and J.M. Drazen. 1995. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat. Genet. 11:150-154.
17. Hadeiba, H., D.B. Corry, and R.M. Locksley. 2000. Baseline airway hyperreactivity in A/J mice is not mediated by cells of the adaptive immune system. J. Immunol. 164:4933-4940.
18. Ackerman, K.G., H. Huang, H. Grasemann, C. Puma, J.B. Singer, A.E. Hill, E. Lander, J.H. Nadeau, G.A. Churchill, J.M. Drazen, and D.R. Beier. 2005. Interacting loci cause airway hyperresponsiveness. Physiol. Genomics. In press.
19. Shinagawa, K., and M. Kojima. 2003. Mouse model of airway remodeling: strain differences. Am. J. Respir. Crit. Care Med. 168:959-967.
20. Piggott, D.A., S.C. Eisenbarth, L. Xu, S.L. Constant, J.W. Huleatt, C.A. Herrick, and K. Bottomly. 2005. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J. Clin. Invest. 115:459-467.
21. Kheradmand, F., A. Kiss, J. Xu, S.H. Lee, P.E. Kolattukudy, and D.B. Corry. 2002. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169:5904-5911.
22. Yu, C.K., and C.L. Chen. 2003. Activation of mast cells is essential for development of house dust mite Dermatophagoides farinaeinduced allergic airway inflammation in mice. J. Immunol. 171:3808-3815.
23. Ikeda, R.K., M. Miller, J. Nayar, L. Walker, J.Y. Cho, K. McElwain, S. McElwain, E. Raz, and D.H. Broide. 2003. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J. Immunol. 171:4860-4867.
24. Shen, H.H., S.I. Ochkur, M.P. McGarry, J.R. Crosby, E.M. Hines, M.T. Borchers, H. Wang, T.L. Biechelle, K.R. O'Neill, T.L. Ansay, et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 170:3296-3305.
25. Mattes, J., M. Yang, S. Mahalingam, J. Kuehr, D.C. Webb, L. Simson, S.P. Hogan, A. Koskinen, A.N. McKenzie, L.A. Dent, et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195:1433-1444.
26. Humbles, A.A., B. Lu B, D.S. Friend, S. Okinaga, J. Lora, A. Al-Garawi, T.R. Martin, N.P. Gerard, and C. Gerard. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergeninduced airway inflammation and hyperresponsiveness. Proc. Natl Acad. Sci. USA. 99:1479-1484.
27. Hamelmann, E., G. Cieslewicz, J. Schwarze, T. Ishizuka, A. Joetham, C. Heusser, and E.W. Gelfand. 1999. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 160:934-941.
28. Lee, J.J., D. Dimina, M.P. Macias, S.I. Ochkur, M.P. McGarry, K.R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S.A. Cormier, E. Lenkiewicz, D. Colbert D, L. Rinaldi, S.J. Ackerman, C.G. Irvin CG, and N.A. Lee. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science. 305:1773-1776.
29. Humbles, A.A., C.M. Lloyd, S.J. McMillan, D.S. Friend, G. Xanthou, E.E. McKenna, S. Ghiran, N.P. Gerard, C. Yu, S.H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science. 305:1776-1779.
30. Kobayashi, T., K. Iijima, and H. Kita. 2003. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J. Immunol. 170:5756-5763.
31. Cho, J.Y., M. Miller, K.J. Baek, J.W. Han, J. Nayar, S.Y. Lee, K. McElwain, S. McElwain, S. Friedman, and D.H. Broide. 2004. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest. 113:551-560.
32. Henderson, W.R., Jr., L.O. Tang, S.J. Chu, S.M. Tsao, G.K. Chiang, F. Jones, M. Jonas, C. Pae, H. Wang, and E.Y. Chi. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165:108-116.
33. Taube, C., X. Wei X, C.H. Swasey, A. Joetham, S. Zarini, T. Lively, K. Takeda, J. Loader, N. Miyahara, T. Kodama, L.D. Shultz, D.D. Donaldson, E.H. Hamelmann, A. Dakhama, and E.W. Gelfand. 2004. Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 172:6398-6406.
34. Martin, T.R., T. Takeishi, H.R. Katz, K.F. Austen, J.M. Drazen, and S.J. Galli. 1993. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J. Clin. Invest. 91:1176-1182.
35. Mayr, S.I., R.I. Zuberi, M. Zhang, J. de Sousa-Hitzler, K. Ngo, Y. Kuwabara, L. Yu, W.P. Fung-Leung, F.T. Liu. 2002. IgEdependent mast cell activation potentiates airway responses in murine asthma models. J. Immunol. 169:2061-2068.
36. Ichinose, M., and P.J. Barnes. 2004. Cytokine-directed therapy in asthma. Curr. Drug Targets - Inflamm. Allergy. 3:263-269.